XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefits (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Expenses -Included in Consolidated Statement of Income
The following tables summarize total stock-based compensation expense included on our Consolidated Statements of Income as broken down by award type and by expense type:
Year Ended December 31,
(in millions)202220212020
RSUs$557 $558 $546 
PSUs25 17 25 
Stock options28 29 44 
ESPP26 31 28 
Acquisition-related expense(1)
— 433 
Stock-based compensation expense included in total costs and expenses$645 $635 $1,076 
________________________________
(1)    Accelerated post-acquisition stock-based compensation expense of $8 million related to the MiroBio acquisition in 2022, and $289 million and $144 million related to the acquisitions of Immunomedics and Forty Seven, respectively, in 2020.
Year Ended December 31,
(in millions)202220212020
Cost of goods sold$46 $40 $109 
Research and development expenses285 287 462 
Selling, general and administrative expenses313 308 505 
Stock-based compensation expense included in total costs and expenses645 635 1,076 
Income tax effect(91)(100)(222)
Stock-based compensation expense, net of tax$553 $535 $854 
RSU Activity
The following tables summarize our RSU activity:
RSUs
(in millions, except per share amounts)SharesWeighted-
Average
Grant Date Fair Value Per Share
Outstanding as of December 31, 202120.9 $67.48 
Granted13.7 $60.36 
Vested(8.9)$67.63 
Forfeited(2.2)$63.76 
Outstanding as of December 31, 202223.6 $63.62 
Year Ended December 31,
(in millions, except per share amounts)202220212020
Weighted-average grant date fair value of RSUs granted$60.36 $65.42 $70.94 
Total fair value of RSUs as of the respective vesting dates
$554 $463 $444 
PSU Activity
The following tables summarize our PSU activity:
PSUs
(in millions, except per share amounts)SharesWeighted-
Average
Grant Date Fair Value Per Share
Outstanding as of December 31, 20210.7 $79.13 
Granted0.6 $60.04 
Vested(0.2)$68.24 
Forfeited(0.1)$59.04 
Outstanding as of December 31, 20221.0 $64.28 
Year Ended December 31,
(in millions, except per share amounts)202220212020
Weighted-average grant date fair value of PSUs granted$60.04 $71.31 $83.64 
Total fair value of PSUs as of the respective vesting dates$14 $$15 
Activity Under Stock Option Plans
The following tables summarize activity and other information related to our stock options:
Shares
(in millions)
Weighted-
Average
Exercise Price
(in dollars)
Weighted-Average
Remaining
Contractual Term
(years)
Aggregate
 Intrinsic
Value
(in millions)(1)
Outstanding as of December 31, 202116.8 $70.60 
Granted4.1 $58.59 
Forfeited(0.6)$62.84 
Expired(2.5)$82.37 
Exercised(3.5)$61.11 
Outstanding as of December 31, 202214.4 $67.69 6.61$271 
Exercisable as of December 31, 20227.9 $72.32 5.00$115 
Expected to vest, net of estimated forfeitures as of December 31, 20226.2 $62.16 8.55$146 
________________________________
(1)     Aggregate intrinsic value represents the value of our closing stock price on the last trading day of the year in excess of the weighted-average exercise price multiplied by the number of options outstanding or exercisable.
Year Ended December 31,
(in millions, except per share amounts)202220212020
Weighted-average grant date fair value of stock options granted$9.08 $10.05 $11.69 
Total intrinsic value of options exercised$59 $48 $179 
Schedule of Assumptions to Calculate the Estimated Fair Value of Awards
We used the following weighted-average assumptions in the Black-Scholes model to calculate the estimated fair value of the stock option awards:
Year Ended December 31,
(in millions)202220212020
Expected volatility27 %29 %29 %
Expected terms in years555
Risk-free interest rate1.9 %0.8 %0.8 %
Expected dividend yield4.3 %4.4 %4.0 %
We used the following weighted-average assumptions in the Black-Scholes model to calculate the estimated fair value of the ESPP awards:
Year Ended December 31,
202220212020
Expected volatility23 %25 %28 %
Expected terms in years0.50.50.5
Risk-free interest rate1.8 %0.1 %0.6 %
Expected dividend yield4.5 %4.4 %4.0 %
ESPP Activity
The following table summarizes our ESPP activity:
Year Ended December 31,
(in millions, except per share amounts)202220212020
Shares issued
Amount paid by employees for shares$103 $111 $100 
Weighted-average grant date fair value of ESPP shares granted$13.40 $14.58 $15.09 
Total fair value of ESPP shares as of the respective vesting dates
$21 $23 $24